BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7626311)

  • 1. Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide.
    Yamaguchi T; Sugimoto T; Imai Y; Fukase M; Fujita T; Chihara K
    Bone; 1995 Apr; 16(4 Suppl):247S-250S. PubMed ID: 7626311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide.
    Lufkin EG; Wilson DM; Smith LH; Bill NJ; DeLuca HF; Dousa TP; Knox FG
    J Clin Endocrinol Metab; 1980 Apr; 50(4):648-53. PubMed ID: 7364922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
    Dumitrescu CE; Kelly MH; Khosravi A; Hart TC; Brahim J; White KE; Farrow EG; Nathan MH; Murphey MD; Collins MT
    Osteoporos Int; 2009 Jul; 20(7):1273-8. PubMed ID: 18982401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumoral calcinosis with hyperphosphatemia.
    Mahadevan S; Adhisivam B; Kumar CN
    Indian J Pediatr; 2005 Oct; 72(10):889-90. PubMed ID: 16272668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis.
    Steinherz R; Chesney RW; Eisenstein B; Metzker A; DeLuca HF; Phelps M
    Am J Dis Child; 1985 Aug; 139(8):816-9. PubMed ID: 3839626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and phosphate metabolism in tumoral calcinosis.
    Mitnick PD; Goldfarb S; Slatopolsky E; Lemann J; Gray RW; Agus ZS
    Ann Intern Med; 1980 Apr; 92(4):482-7. PubMed ID: 6244768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms.
    Finer G; Price HE; Shore RM; White KE; Langman CB
    Am J Med Genet A; 2014 Jun; 164A(6):1545-9. PubMed ID: 24668887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
    Lammoglia JJ; Mericq V
    Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate.
    Emecen Sanli M; Kilic A; Aktasoglu E; Inci A; Okur I; Ezgu F; Tumer L
    J Pediatr Endocrinol Metab; 2021 Jun; 34(6):813-816. PubMed ID: 33819418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide.
    Verberckmoes R; Bouillon R; Krempien B
    Ann Intern Med; 1975 Apr; 82(4):529-33. PubMed ID: 1119767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phosphorus metabolism in a case of tumoral calcinosis].
    Bard H; Kuntz D; Molle D; Witvoet J; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 Feb; 51(2):63-8. PubMed ID: 6710063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperostosis with hyperphosphatemia and tumoral calcinosis: a case report.
    Otukesh H; Hoseini R; Chalian H; Chalian M; Safarzadeh AE; Shakiba M; Poorian A
    Pediatr Nephrol; 2007 Aug; 22(8):1235-7. PubMed ID: 17437133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumoral calcinosis: clinical and metabolic response to phosphorus deprivation.
    Davies M; Clements MR; Mawer EB; Freemont AJ
    Q J Med; 1987 Jun; 63(242):493-503. PubMed ID: 3659264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tumoral calcinosis with phosphorus deprivation.
    Mozaffarian G; Lafferty FW; Pearson OH
    Ann Intern Med; 1972 Nov; 77(5):741-5. PubMed ID: 4538804
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperphosphatemic tumoral calcinosis: a 10-year follow-up.
    Alves C; Lima R
    J Pediatr Endocrinol Metab; 2011; 24(1-2):25-7. PubMed ID: 21528811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumoral calcinosis in an infant.
    Bostrom B
    Am J Dis Child; 1981 Mar; 135(3):246-7. PubMed ID: 7211781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphate depletion therapy in two ectopic calcification syndromes.
    Chausmer A; Meyer W; Prince M
    J Am Coll Nutr; 1982; 1(3):275-83. PubMed ID: 7185859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action.
    Lufkin EG; Kumar R; Heath H
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1319-22. PubMed ID: 6687726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic sporadic tumoral calcinosis of the hip: successful oral bisphosphonate therapy.
    Jacob JJ; Mathew K; Thomas N
    Endocr Pract; 2007; 13(2):182-6. PubMed ID: 17490934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumoral calcinosis with unusual presentation. A case report.
    Rambani R; Dhillon MS; Aggarwal R
    Acta Orthop Belg; 2003 Aug; 69(4):368-72. PubMed ID: 14526645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.